170 related articles for article (PubMed ID: 8355147)
21. Mechanism of action of non-cisplatin type DNA-targeted platinum anticancer agents: DNA interactions of novel acridinylthioureas and their platinum conjugates.
Baruah H; Rector CL; Monnier SM; Bierbach U
Biochem Pharmacol; 2002 Jul; 64(2):191-200. PubMed ID: 12123739
[TBL] [Abstract][Full Text] [Related]
22. A molecular modeling study of B-DNA-intercalation complexes with amsacrine and related 9-anilino-acridines.
Fischer G; Pindur U
Pharmazie; 1999 Feb; 54(2):83-93. PubMed ID: 10084153
[TBL] [Abstract][Full Text] [Related]
23. Study of nitrogen heterocycles as DNA/HSA binder, topoisomerase inhibitors and toxicological safety.
Dos Santos JC; Alves JEF; de Azevedo RDS; de Lima ML; de Oliveira Silva MR; da Silva JG; da Silva JM; de Carvalho Correia AC; do Carmo Alves de Lima M; de Oliveira JF; de Moura RO; de Almeida SMV
Int J Biol Macromol; 2024 Jan; 254(Pt 3):127651. PubMed ID: 37949265
[TBL] [Abstract][Full Text] [Related]
24. Dynamic structure of DNA complexes. Fluorometric measurement of hydrogen-deuterium exchange kinetics of dna-bound ethidium dimer and acridine-ethidium dimer.
Markovits J; Ramstein J; Roques BP; Le Pecq JB
Biochemistry; 1983 Jun; 22(13):3231-7. PubMed ID: 6882747
[TBL] [Abstract][Full Text] [Related]
25. DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II.
Rowe TC; Chen GL; Hsiang YH; Liu LF
Cancer Res; 1986 Apr; 46(4 Pt 2):2021-6. PubMed ID: 3004716
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and structure-activity studies of peptide-acridine/acridone conjugates.
Kukowska-Kaszuba M; Dzierzbicka K
Curr Med Chem; 2007; 14(29):3079-104. PubMed ID: 18220744
[TBL] [Abstract][Full Text] [Related]
27. From amsacrine to DACA (N-[2-(dimethylamino)ethyl]acridine-4-carboxamide): selectivity for topoisomerases I and II among acridine derivatives.
Finlay GJ; Riou JF; Baguley BC
Eur J Cancer; 1996 Apr; 32A(4):708-14. PubMed ID: 8695277
[TBL] [Abstract][Full Text] [Related]
28. Unprecedented dual binding behaviour of acridine group of dye: a combined experimental and theoretical investigation for the development of anticancer chemotherapeutic agents.
Rajendran A; Nair BU
Biochim Biophys Acta; 2006 Dec; 1760(12):1794-801. PubMed ID: 16997475
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of the topoisomerase II poison 9-amino-[N-(2-dimethylamino)ethyl]acridine-4-carboxamide bound to the DNA hexanucleotide d(CGTACG)2.
Adams A; Guss JM; Collyer CA; Denny WA; Wakelin LP
Biochemistry; 1999 Jul; 38(29):9221-33. PubMed ID: 10413496
[TBL] [Abstract][Full Text] [Related]
30. DNA bifunctional intercalators. I. Synthesis and conformational properties of an ethidium homodimer and of an acridine ethidium heterodimer.
Gaugain B; Barbet J; Oberlin R; Roques BP; Le Pecq JB
Biochemistry; 1978 Nov; 17(24):5071-8. PubMed ID: 31902
[TBL] [Abstract][Full Text] [Related]
31. Amino- and glycoconjugates of pyrido[4,3,2-kl]acridine. Synthesis, antitumor activity, and DNA binding.
Bouffier L; Baldeyrou B; Hildebrand MP; Lansiaux A; David-Cordonnier MH; Carrez D; Croisy A; Renaudet O; Dumy P; Demeunynck M
Bioorg Med Chem; 2006 Nov; 14(22):7520-30. PubMed ID: 16879973
[TBL] [Abstract][Full Text] [Related]
32. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of modified acridines: the effect of N- and O- substituent in the nitrogenated ring on antitumor activity.
Sánchez I; Reches R; Caignard DH; Renard P; Pujol MD
Eur J Med Chem; 2006 Mar; 41(3):340-52. PubMed ID: 16413635
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, DNA Binding, and Antiproliferative Activity of Novel Acridine-Thiosemicarbazone Derivatives.
de Almeida SM; Lafayette EA; da Silva LP; Amorim CA; de Oliveira TB; Ruiz AL; de Carvalho JE; de Moura RO; Beltrão EI; de Lima Mdo C; de Carvalho Júnior LB
Int J Mol Sci; 2015 Jun; 16(6):13023-42. PubMed ID: 26068233
[TBL] [Abstract][Full Text] [Related]
35. Molecular recognition between a new pentacyclic acridinium salt and DNA sequences investigated by optical spectroscopic techniques, proton nuclear magnetic resonance spectroscopy, and molecular modeling.
Bostock-Smith CE; Giménez-Arnau E; Missailidis S; Laughton CA; Stevens MF; Searle MS
Biochemistry; 1999 May; 38(21):6723-31. PubMed ID: 10346892
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of human CYP1A2 oxidation of 5,6-dimethyl-xanthenone-4-acetic acid by acridines: a molecular modelling study.
Paxton JW; Kestell P; Chiang D; Zhou S; Lewis DF
Clin Exp Pharmacol Physiol; 2005 Aug; 32(8):633-9. PubMed ID: 16120190
[TBL] [Abstract][Full Text] [Related]
37. Fluorescence lifetime analysis of DNA intercalated ethidium bromide and quenching by free dye.
Heller DP; Greenstock CL
Biophys Chem; 1994 Jun; 50(3):305-12. PubMed ID: 8011950
[TBL] [Abstract][Full Text] [Related]
38. [The structural and functional analysis of the biological activity of acridine derivatives].
Deeva EG; Pavlovskaia IaV; Kiselev OI; Kiselev VI; Piotrovskiĭ LB; Ershov FI
Vestn Ross Akad Med Nauk; 2004; (2):29-34. PubMed ID: 15101206
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, antitumor cytotoxicity, and DNA-binding of novel N-5,2-di(omega-aminoalkyl)-2,6-dihydropyrazolo[3,4,5-kl]acridine-5-carboxamides.
Antonini I; Polucci P; Magnano A; Martelli S
J Med Chem; 2001 Sep; 44(20):3329-33. PubMed ID: 11563932
[TBL] [Abstract][Full Text] [Related]
40. Antitumor polycyclic acridines. 7. Synthesis and biological properties of DNA affinic tetra- and pentacyclic acridines.
Stanslas J; Hagan DJ; Ellis MJ; Turner C; Carmichael J; Ward W; Hammonds TR; Stevens MF
J Med Chem; 2000 Apr; 43(8):1563-72. PubMed ID: 10780913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
